As Aerie Pharmaceuticals (AERI) Share Price Declined, Holder Baker Bros Advisors LP Has Lowered by $4.52 Million Its Holding; Donald Smith & Company Increases Stake in Era Group (ERA)

June 14, 2018 - By Vivian Currie

Era Group Inc. (NYSE:ERA) Logo

Donald Smith & Company Inc increased its stake in Era Group Inc (ERA) by 69.18% based on its latest 2018Q1 regulatory filing with the SEC. Donald Smith & Company Inc bought 329,397 shares as the company’s stock rose 31.49% while stock markets declined. The institutional investor held 805,517 shares of the transportation company at the end of 2018Q1, valued at $7.53 million, up from 476,120 at the end of the previous reported quarter. Donald Smith & Company Inc who had been investing in Era Group Inc for a number of months, seems to be bullish on the $279.78 million market cap company. The stock decreased 0.69% or $0.09 during the last trading session, reaching $12.9. About 21,904 shares traded. Era Group Inc. (NYSE:ERA) has risen 41.01% since June 14, 2017 and is uptrending. It has outperformed by 28.44% the S&P500. Some Historical ERA News: 17/05/2018 – S&PGR Affirms Era Group Inc. ‘B-‘ Ratings; Outlook Negative; 25/05/2018 – HELICOPTER SERVICE ERA BEGAN GOM OIL,GAS EVACUATIONS ON ALBERTO; 08/03/2018 – ERA GROUP 4Q OPER REV. $57.5M; 01/05/2018 – ERA GROUP 1Q LOSS/SHR 6C; 08/03/2018 Era Group 4Q EPS $2.89; 20/04/2018 – DJ Era Group Inc, Inst Holders, 1Q 2018 (ERA); 08/03/2018 – Era Group 4Q Rev $57.5M; 01/05/2018 – ERA GROUP 1Q OPER REV. $57.3M

Julian Baker decreased its stake in Aerie Pharmaceuticals Inc. (AERI) by 27.96% based on its latest 2018Q1 regulatory filing with the SEC. Baker Bros Advisors Lp sold 83,701 shares as the company’s stock declined 7.63% with the market. The hedge fund run by Julian Baker held 215,655 shares of the health care company at the end of 2018Q1, valued at $11.70M, down from 299,356 at the end of the previous reported quarter. Baker Bros Advisors Lp who had been investing in Aerie Pharmaceuticals Inc. for a number of months, seems to be less bullish one the $2.52 billion market cap company. The stock increased 1.35% or $0.85 during the last trading session, reaching $63.85. About 133,629 shares traded. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has declined 8.48% since June 14, 2017 and is downtrending. It has underperformed by 21.05% the S&P500. Some Historical AERI News: 22/04/2018 – DJ Aerie Pharmaceuticals Inc, Inst Holders, 1Q 2018 (AERI); 09/05/2018 – Aerie Short-Interest Ratio Rises 38% to 30 Days; 30/05/2018 – Aerie Pharmaceuticals Announces Appointment of Lily Nguyen as Director, Project Management; 31/05/2018 – AMERICAN EAGLE OUTFITTERS INC – BY BRAND, AMERICAN EAGLE’S QTRLY COMPARABLE SALES INCREASED 4% AND AERIE’S COMPARABLE SALES INCREASED 38%; 30/04/2018 – Aerie Pharmaceuticals: Rhopressa for Reduction of Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension; 08/05/2018 – Aerie Pharmaceuticals 1Q Loss/Shr $1.05; 24/04/2018 – Aerie Role Models’ Mothers Appear in New Campaign; 22/03/2018 – Total Retail: A Commitment to Core Brand Values Helps Aerie Prosper; 30/04/2018 – Aerie Pharmaceuticals Announces U.S. Launch of Rhopressa® (netarsudil ophthalmic solution) 0.02%; 24/04/2018 – Aerie Short-Interest Ratio Rises 58% to 22 Days

Investors sentiment decreased to 1.19 in 2018 Q1. Its down 0.01, from 1.2 in 2017Q4. It dropped, as 18 investors sold AERI shares while 46 reduced holdings. 17 funds opened positions while 59 raised stakes. 39.43 million shares or 13.11% more from 34.86 million shares in 2017Q4 were reported. Perigon Wealth Mgmt Ltd Liability Co holds 0.02% of its portfolio in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 1,098 shares. Consulate reported 10,500 shares or 0.3% of all its holdings. Suffolk Ltd Liability Corp has 1.65% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Bamco Ny has 0% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 14,769 shares. Proshare Advsr Ltd Liability Co owns 21,907 shares. Legal & General Gp Plc stated it has 12,448 shares. New Jersey-based Prudential Fin has invested 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Manchester Capital Limited Liability Com holds 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) or 150 shares. Essex Investment Mngmt Co Limited Co has invested 0.55% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Employees Retirement Association Of Colorado holds 0% or 2,940 shares. Dekabank Deutsche Girozentrale owns 15,600 shares or 0.01% of their US portfolio. Sectoral Asset Mngmt has 538,618 shares. Pnc Fincl holds 38 shares. Ameritas Investment has 2,805 shares for 0.01% of their portfolio. Sei Invests holds 0% or 4,924 shares in its portfolio.

Baker Bros Advisors Lp, which manages about $8.20B and $11.80 billion US Long portfolio, upped its stake in Ascendis Pharma A/S by 218,534 shares to 2.84M shares, valued at $185.56M in 2018Q1, according to the filing. It also increased its holding in Chemocentryx Inc. (NASDAQ:CCXI) by 364,965 shares in the quarter, for a total of 414,029 shares, and has risen its stake in Heron Therapeutics Inc. (NASDAQ:HRTX).

Among 15 analysts covering Aerie Pharmaceuticals (NASDAQ:AERI), 15 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aerie Pharmaceuticals had 53 analyst reports since August 7, 2015 according to SRatingsIntel. H.C. Wainwright maintained Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) on Wednesday, August 2 with “Buy” rating. Stifel Nicolaus maintained the shares of AERI in report on Tuesday, January 2 with “Buy” rating. The rating was maintained by RBC Capital Markets with “Outperform” on Friday, October 28. Needham maintained it with “Buy” rating and $52 target in Thursday, September 15 report. The firm has “Buy” rating given on Friday, September 15 by Needham. The stock has “Buy” rating by Mizuho on Wednesday, September 6. The firm has “Buy” rating by Cantor Fitzgerald given on Wednesday, February 28. The stock of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has “Buy” rating given on Thursday, March 29 by Mizuho. The stock of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) earned “Buy” rating by Cowen & Co on Tuesday, September 26. Canaccord Genuity maintained it with “Buy” rating and $6500 target in Tuesday, August 1 report.

Analysts await Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) to report earnings on August, 7. They expect $-0.96 EPS, down 17.07% or $0.14 from last year’s $-0.82 per share. After $-1.05 actual EPS reported by Aerie Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -8.57% EPS growth.

Since May 21, 2018, it had 2 insider buys, and 3 sales for $10.02 million activity. ANIDO VICENTE JR sold $9.34M worth of stock. Shares for $50,245 were bought by Cagle Gerald D. on Monday, May 21.

More recent Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) news were published by: Gurufocus.com which released: “Aerie Pharmaceuticals Inc (AERI) CEO Vicente Jr Anido Sold $9.3 million of Shares” on June 09, 2018. Also Streetinsider.com published the news titled: “Aerie Pharma (AERI): Early Physician Rhopressa Feedback is Cautiously Positive – Cowen” on May 24, 2018. Businesswire.com‘s news article titled: “Aerie Pharmaceuticals to Present at the Jefferies 2018 Global Healthcare Conference” with publication date: May 31, 2018 was also an interesting one.

Donald Smith & Company Inc, which manages about $6.25 billion and $3.74B US Long portfolio, decreased its stake in Sanmina Corporation (NASDAQ:SANM) by 139,624 shares to 2.53M shares, valued at $66.21M in 2018Q1, according to the filing. It also reduced its holding in Xl Group by 200,306 shares in the quarter, leaving it with 554,084 shares, and cut its stake in Micron Technology (NASDAQ:MU).

Since March 12, 2018, it had 0 insider purchases, and 12 insider sales for $487,359 activity. Another trade for 16,367 shares valued at $157,873 was sold by White Paul T. Shares for $13,123 were sold by Stavley Stuart on Tuesday, March 20. Another trade for 622 shares valued at $5,971 was made by Whalen Jennifer Dawn on Tuesday, March 20.

Investors sentiment decreased to 1.13 in 2018 Q1. Its down 0.30, from 1.43 in 2017Q4. It dived, as 6 investors sold ERA shares while 33 reduced holdings. 16 funds opened positions while 28 raised stakes. 18.07 million shares or 0.62% less from 18.18 million shares in 2017Q4 were reported. State Common Retirement Fund holds 23,404 shares or 0% of its portfolio. Group has 0% invested in Era Group Inc. (NYSE:ERA). Van Den Berg Management I holds 1.54% or 1.36 million shares. Moreover, United Services Automobile Association has 0.01% invested in Era Group Inc. (NYSE:ERA). 18,223 were reported by Manufacturers Life Insurance The. Comerica National Bank & Trust reported 0% stake. Wells Fargo Mn has 29,350 shares. Ameritas Prtnrs Inc holds 0% of its portfolio in Era Group Inc. (NYSE:ERA) for 1,735 shares. First Mercantile Tru stated it has 5,752 shares. State Of Tennessee Treasury Department reported 13,981 shares. 108,278 are held by Schwab Charles Investment Inc. Bancshares Of America De invested in 15,278 shares. Federated Invsts Inc Pa invested in 0% or 403 shares. Millennium Management Limited Liability holds 0% of its portfolio in Era Group Inc. (NYSE:ERA) for 115,836 shares. Invesco Limited has invested 0% in Era Group Inc. (NYSE:ERA).

Era Group Inc. (NYSE:ERA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Vivian Currie

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts